Zhao, Chong <br/><br/>
Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.  [electronic resource] 

 -  Cancer letters  07 2020 
 - 15-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2020.03.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Autophagosomes--drug effects<br/>Autophagy--drug effects<br/>Caco-2 Cells<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Fluorouracil--pharmacology<br/>HCT116 Cells<br/>HT29 Cells<br/>Humans<br/>Lysosomes--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prodigiosin--pharmacology